Project14 hours ago
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
Telix Pharmaceuticals Limited today announces that the Brazilian Health Regulatory Agency has approved Illuccix® the Company’s lead prostate cancer imaging agent. MELBOURNE, Australia and PORTO ALEGRE,...
